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To assess the role of physician variability in the management of pain and provide quantita-




A multi-item mail survey was used to determine the physician’s perceived knowledge of pain









Overall, 30% of the study group reported no formal education in pain management, although
















 .001). The phy-









 .001 ). In regards to the opinion that prescribing strong opioids would attract a medical review,
the physician responses ranged from 1 (strongly disagree) to 5 (strongly agree). The median score for
this scale was 4, accounting for 46% of the responses. The study group expressed less satisfaction with





Lower expectations for relief and less satisfaction in its management may contribute to
the undertreatment of chronic pain. Perceptions of regulatory scrutiny may contribute to suboptimal
pain management. These preliminary data highlight physician variability in pain decision making




Pain Management; Barriers to Treatment; Physician Variability; Education or Knowl-
edge; Goals and Treatment; Attitudes or Perceptions
C
 
omplaints of pain are one of the most common
reasons patients cite for consulting physicians
for care.[1] This is true even though the pathogen-
esis and epidemiological impact of pain remain
poorly understood and exact significant social and
economic tolls.[2–4] Although a number of physi-
cal, societal, and economic barriers have been iden-
tified that prevent the optimal management of pain
[5,6], there are limited data regarding the physi-
cian’s knowledge of pain management. Less is
known about the impact of physician variation
on pain management. Physician variability in know-
ledge, attitudes, and goals for pain management
may lead to inadequate treatment as well as unnec-
essary suffering of patients with pain.[7–9] This ar-
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ticle reports the results of a study of physicians’
knowledge about pain management as well as their
attitudes and approaches to treating pain.
The adequate management of pain is important
from both a physiological and an emotional stand-
point [10,11]. Multiple strategies, modalities, and
treatments are currently available to control pain,
pain-related symptoms, and side effects from pain
treatment[12–20]. The inadequate assessment and
undertreatment of acute pain, chronic pain (i.e., be-
nign or nonmalignant), cancer pain, and pain asso-
ciated with a terminal illness increases morbidity
and mortality[20–23]. The World Health Organi-
zation (WHO), the U.S. government, professional
societies, and a plethora of special interest groups
have created a framework for numerous pain-spe-
cific educational programs and clinical initiatives
targeted to improve both the assessment and man-
agement of pain[6,12,14,15,24–26].
Significant differences exist in the attitudes of
health care professionals regarding the goals and
treatment of acute and cancer pain [27–33]. These
differences may also exist among clinicians treating
patients with chronic pain or pain resulting from
terminal illness [8,9,27,34,35]. Perceptions of pain
may be influenced by the health care professional’s
personal experiences with pain as well as their
knowledge of the efficacy of different modalities
used for pain management [12,36]. More impor-
tantly, differences in perception may prevent ade-
quate assessment and optimal treatment of pain.
Information is lacking on how barriers to pain
management affect outcome. This lack of informa-
tion coupled with misinformation regarding the
role and mechanism of action of different analge-
sics may limit their use in appropriate settings. In
addition, because perceptions often correlate with
behavior, misperceptions regarding the side effects
of opioid analgesics may limit a physician’s willing-
ness to provide patients with optimal pain manage-
ment. These attitudes may determine when, how,
why, and what type of analgesic modality a physi-
cian may prescribe for the treatment of pain.
The role of regulatory scrutiny and insurance
provider oversight of medical decision making may
discourage physicians from prescribing appropri-
ate analgesics [37]. In the state of Michigan, con-
trolled-substance or Schedule II opioid analgesics
must be prescribed on special prescription forms,
which are monitored by the Michigan State Board
of Medicine. Despite medical judgment supporting
the use of Schedule II opioids for pain manage-
ment, physicians may fear professional scrutiny if
they prescribe this class of opioid analgesics. Mini-
mal information is available about whether physi-
cians use opioid contracts when prescribing opioid
analgesics [38].
Limited information is available about physician
variability in knowledge, attitudes, goals, and per-
ceptions regarding pain management. We hypoth-
esized that differences in pain management may be
due to physician characteristics, attitudes, knowl-
edge, and goals for pain management. We further
speculated that these differences contributed to vari-
ability in decision making, which may be a potential
barrier to adequate pain management. A study was
designed to examine the role of physician variabil-
ity in the management of pain in Michigan. In this
article, we present some descriptive results of a sur-
vey designed for a general population of physicians,
including all specialties. The results presented may
permit some inferences regarding potential physi-




The University of Michigan Health System (UMHS)
Institutional Review Board approved this study. The
investigators developed a four-page survey to pro-
vide a quantitative analysis of pain management in
Michigan. Questions pertaining to physician demo-
graphics, opinions on pain management, and pro-
fessional practice. In addition, clinical vignettes were
developed. The multi-item survey was designed to
obtain the physician’s perceived knowledge of pain
management modalities, goals, satisfaction, and con-
fidence with their treatment of acute, chronic, and
cancer pain. In May 1999, faculty members of the
UMHS Department of Anesthesiology were en-
listed to critique an early draft of the survey instru-
ment. Using face validity, questions that were am-
biguous or lacked clarity were revised, and content
areas that were overlooked were added to enhance
the value of the questionnaire. The second step in
the refinement of the survey tool was to administer
the questionnaire to a pilot group of 14 UMHS
physicians who provide outpatient care and were
not members of the Department of Anesthesiology.
Those questions still having poor face validity were
deleted and substitutions made to the questionnaire.
The final Physician Pain Management Survey con-
sisted of 110 questions. Using the Michigan Board
of Medical Licensure directory of 36,000 physi-
cians, 1,400 licensed medical doctors and doctors of
osteopathy were randomly sampled. In addition, we
included a sample of 373 physicians who referred
patients to the Multidisciplinary Pain Center (MPC)
at UMHS to determine whether there were differ-
 




ences between the two groups. Hence, the survey
was distributed by mail to a total of 1,773 physi-
cians practicing in Michigan. Three follow-ups of
the questionnaire were allowed as described by Dill-
man [39] (i.e., postcard reminders and letters ac-
companied with the survey in a 2-month period) to
provide an optimal response. An abbreviated ques-
tionnaire was mailed to nonresponding physicians
to determine their reasons for not responding. Sam-
ple size calculations were based on a convenience
sample.
Descriptive statistics (i.e., frequency distribu-
tions, means, and percentages) were used to charac-
terize the sample of physicians with respect to de-





 tests for continuous data (e.g., pain
education and knowledge) and confidence intervals
(e.g., physician goals and satisfaction with treat-
ment). Stepwise logistic regression and analysis of
variance (ANOVA) was used to characterize the re-
lationship of the physician attitudes about prescrib-
ing opioids to their frequency of prescribing. Co-
efficients of correlation were also calculated. All









At the end of the response time frame, 1,553 ques-
tionnaires were successfully delivered and 132 were
deemed “undeliverable” because of incorrect ad-
dresses. Three hundred seventy-five questionnaires
were completed and returned. Seven responses were
excluded because they did not meet the eligibility
criteria for the study that “only responses from
physicians that have clinical responsibilities” be in-
cluded, and 219 physicians returned the question-
naire unanswered. A total of 368 survey responses
were entered into a database for analysis. The over-
all response rate was 26%: 33% of nonreferring
physicians and 67% of UMHS referring physicians.
Because no differences were found in the response
rate to either survey or responses to the items on
the survey between the two groups of physicians,
the data from the two groups were combined. The





SD, and the majority of respondents described
their race as White/Caucasian. Demographic char-
acteristics of respondents are presented in Table 1.
Physicians were categorized based on type of prac-
tice as either primary (those who provide basic
medical care) or specialist (those who provide spe-
cialty care and for whom referral is typically re-
quired; Table 2) [41].
Analysis of the 122 nonresponse questionnaires
(11%) revealed that the most common reason for the
physician’s decision not to participate was time con-
straints, consistent with other physician surveys [42].
The age and racial origin of the survey respondents
closely reflected the racial origin of the nonrespon-
dents. Furthermore, the respondents were repre-
sentative of Michigan physicians in terms of per-
sonal demographic and practice characteristics [41].
 
Experience in Treating Pain
 
Physicians were asked to rate the frequency that
they evaluated patients with pain in their practice
(ranging from never to very often) according to the
type of pain (Table 3). The most common type of
pain evaluated by physicians was determined by
adding the “often” and “very often” responses.
The majority of primary physicians (61%) reported
evaluating chronic pain more frequently, whereas
the majority of specialty physicians (52%) reported
evaluating acute pain more frequently. Physicians
were asked to rate the frequency that they pre-
scribed pain treatment for each type of pain (Table
4). For acute pain, specialty physicians prescribed
more frequently than primary physicians (52% vs.

























































































chronic pain more frequently than specialty physi-
cians (45% vs. 31%).
 
Pain Education and Knowledge
 
Thirty percent of physicians reported that they did
not receive any pain management education during
medical school, residency training, or via continu-
ing medical education (CME). Only 10% of the
physicians reported pain education during medical
school, residency training, and via CME (Table 5).
The cumulative pain education of the physicians by
age is shown in Figure 1. There is a negative corre-

















between age and education that is independent of
practice type. Younger physicians were more likely
to have received formal pain management educa-
tion than older physicians.
The survey assessed perceived knowledge of
pain treatment modalities. Figure 2 illustrates how
confident physicians were in their knowledge of
several pain treatment modalities. For the purposes
of this study, Schedule II opioids, which require the
use of the state of Michigan official prescription
form, were described as “triplicate.” Opioids that
did not require a special prescription were defined
as “nontriplicate.” The results for the triplicate
drug meperidine are considered separately because
of its unique pharmacology and concerns regarding
toxicity [43–45]. The other two modalities were
nerve blocks (physician intervention) and transcu-
taneous electrical nerve stimulation (TENS) unit (a
nonpharmacological method). Figure 3 shows the
physicians’ perceived confidence in their knowl-
edge of different pain treatment modalities by their
practice category. Both specialty and primary phy-
sicians reported a greater knowledge of meperidine,
nontriplicate, and triplicate drugs, whereas their





 tests were used to determine the difference
between the mean scores of pain treatment knowl-
edge, only their knowledge of nerve blocks was sig-









 .0001); specialty physicians reported a









Areas of practice N n Row % n Row %
Primary Internal Medicine 100 30 30.0 70 70.0
OB/GYN 34 14 40.0 20 57.1
Family/ General Practice 71 18 25.0 53 73.6
Pediatrics 23 12 50.0 11 45.8
Total in category 228 74 32.5 154 67.5
Specialty Surgery 71 9 12.7 62 87.3
Anesthesiology 15 2 13.3 13 86.7
Physical Medicine/ Rehab. 15 4 26.7 11 73.3
Neurology 6 3 50.0 3 50.0
Psychiatry 12 2 16.7 10 83.3
Other 14 3 21.4 11 78.6
Total for category 133 23 17.3 110 82.7




Frequency of pain treatment by type of pain and physician practice category
 
Type of pain Practice category
Frequency of treatment
Number of Physicians (% within practice category)
Total Nnever sometimes often very often
Acute Primary 75 (32.4) 105 (45.4) 31 (13.4) 20 (8.6) 231
Specialist 32 (24.6) 30 (23) 17 (13) 51 (39.2) 120
Chronic Primary 15 (6.5) 75 (32.7) 96 (41.9) 43 (18.7) 219
Specialist 19 (14.3) 48 (36.3) 37 (28) 28 (21.2) 132
Cancer Primary 76 (33.1) 115 (50.2) 23 (10) 15 (6.5) 229
Specialist 48 (36.9) 66 (50.7) 12 (9.2) 4 (3) 130
Terminal Illness Primary 75 (33) 107 (47.1) 26 (11.4) 19 (8.3) 227
Specialist 51 (39.5) 62 (48) 12 (9.3) 4 (3.1) 129
 




mary physicians (2.8 vs. 2.0). Two-way ANOVA









educational group in physician knowledge of drugs
and treatments, except for meperidine. When phy-
sicians reported a greater number of pain programs
attended (i.e., medical school, residency, or CME),
their reported knowledge of pain treatments was
significantly greater (Figure 4).
 
Physician Goals and Satisfaction With
Pain Management
 
Physicians were asked to identify their goals for the
management of all types of pain. Table 6 shows the
physicians’ goals for pain management by the type
of pain. Using the categories of absolute and com-
plete pain relief, adequate pain relief without dis-
tress, moderate pain relief, or pain relief only during
painful periods, more than 75% of the physicians
reported a goal of adequate pain relief without dis-
tress. Physicians more frequently reported a goal of
absolute and complete pain relief when asked about
the management of cancer and the pain of terminal
illness (24.8% vs. 38.2%) but reported this goal less
frequently for chronic pain (5.4%). When specifi-
cally asked about treating chronic pain, more than
90% of physicians reported a goal of either ade-
quate pain relief without distress or moderate pain
relief. When evaluating the confidence intervals, a
positive shift for the physicians reported goals for
the management of acute pain (mean: 4.2; 95% CI:
4.1–4.2), cancer pain (mean: 4.2; 95% CI: 4.1–4.3),
and the pain of terminal illness (mean: 4.3; 95% CI:
4.3–4.4) was noted compared with their goals for
chronic pain management (mean: 3.8; 95% CI: 3.8–
3.9). In these instances, the physicians reported a
goal of absolute and complete pain relief or ade-
quate pain relief without distress.
Physicians were asked to report their level of sat-
isfaction with the pain care they provide on a five-
point scale ranging from 1 (extremely dissatisfied)
to 5 (extremely satisfied). Table VII shows that, over-
all, physicians were satisfied with the pain care they
provided and consistently reported scores of 3 or




Frequency of prescribing pain treatments by type of pain and physician practice category
 
Type of pain Practice category
Frequency of Prescription
Number of Physicians (% within practice category)
Total Nnever sometimes often very often
Acute Primary 83 (36.7) 66 (29.2) 46 (20.3) 31 (13.7) 226
Specialist 41 (31.2) 22 (16.7) 15 (11.4) 53 (40.4) 131
Chronic Primary 23 (10.1) 102 (45.1) 80 (35.3) 21 (9.2) 226
Specialist 33 (25.1) 57 (43.5) 27 (20.6) 14 (10.6) 131
Cancer Primary 76 (33.7) 63 (28) 49 (21.7) 36 (16) 224
Specialist 56 (43.0) 51 (39.2) 13 (10) 10 (7.6) 130
Terminal illness Primary 78 (34.6) 64 (28.4) 41 (18.2) 41 (18.2) 224




Number of medical training programs with pain 




Specialty (N %) Primary N (%) N (%)
None 44 (41) 64 (59) 108 (29.7)
1 43 (36) 76 (64) 119 (32.7)
2 33 (32) 70 (67) 103 (28.3)
3 13 (38) 21 (62) 34 (9.3)
Total n (%) 133 (36.5) 231 (63.5) 364 (100)
 
*Including medical school, residency and continuing medical education
(CME)







the primary physicians were significantly more satis-
fied with the level of pain care provided to cancer
and terminally ill patients and less satisfied with the
care provided to patients with acute pain (Figure 5).
The level of satisfaction with the care provided to
chronic pain patients was not significantly different
between the primary and the specialty physicians
but was the lowest satisfaction level reported over-
all.
 
Opinions on Issues Related to Regulatory Scrutiny
 
The majority of the study group (71%) owned a
state of Michigan official prescription book for pre-
scribing Schedule II drugs. Primary physicians were
more likely to prescribe chronic opioids for chronic
pain than specialty physicians (59% vs. 28%). A mi-
nority of physicians (36%) reported the use of opi-
oid contracts for patients using opioids for chronic
pain.
Physicians were asked to rate their level of
agreement on issues related to regulatory scrutiny
(Table 8). Respondents reported a range of re-
sponses (moderately disagree to moderately agree)
in whether they believe that there was undue regu-
latory scrutiny of their prescribing strong opioids
for pain (1.8–4.0). Physicians also varied in their
level of agreement (moderately agree to moderately
disagree) in regards to the experience of their col-
leagues as to whether regulatory agencies had af-
fected their prescribing strong opioids for pain
(1.2–3.8). However, they tended to agree that pre-





Minimal attention has been devoted to understand-
ing the potential educational, regulatory, and atti-
Figure 2 Distribution of Michigan physicians knowledge of
pain treatments.
Figure 4 Pain treatment knowledge of Michigan physicians
by the level of pain education.
Figure 3 Distribution of Michigan physicians confidence of




Percentage distribution of Michigan physician 

















n (%) n (%) n (%) n (%)
Acute 59 (17.4) 272 (80) 5 (1.5) 4 (1.2)
Cancer 63 (24.8) 174 (68.5) 16 (6.3) 1 (0.4)
Terminally ill 94 (38.2) 137 (55.7) 12 (4.9) 3 (1.2)
Chronic 18 (5.4) 237 (71.1) 67 (20.1) 11 (3.3)
 




tudinal barriers to optimal pain management. Al-
though it is well known that incomplete knowledge
and differing physician attitudes about pain control
contribute to the inadequate assessment and con-
tinued undertreatment of pain [7,27,46], less is
known about the determinants of knowledge and
attitudes. This study has presented new informa-
tion about physician pain education, attitudes, and
goals concerning pain management to shed light on
barriers to effective pain management. Results of
this study showed that there is considerable vari-
ability in Michigan physician’s knowledge of the
modalities used for pain management.
Our study results again support the conclusion
that the pain management education of physicians
is generally inadequate [1]. It further highlights the
paucity of educational efforts directed at pain man-
agement during medical school and residency train-
ing or via physician CME programs. It is revealing
in that nearly one third of the study group reported
they had never received any formal education in
pain management. Furthermore, members of the
study group who did receive some formal pain edu-
cation described it as minimal. However, younger
physicians reported significantly more pain man-
agement education than did older physicians [22].
Further study is necessary to determine whether
this is due to redesigned educational efforts or to
differing attitudes regarding pain.
The importance of increased education in pain
management is clear [47]. Von Roenn [27] concluded
that the lack of formal cancer pain education and
training among physicians resulted in the under-
treatment of cancer pain. Furthermore, Rabow et al.
revealed that, in the 50 top-selling medical books,
little information was provided regarding end-of-
life patient care [48]. However, Weinstein and col-
leagues revealed that traditional pain management
education is unlikely to be sufficient for physicians
[8]. Max demonstrated that educational efforts alone
might not be adequate to improve pain management
[22]. Thus, supplementary approaches to changing
physician behavior, including altering attitudes and
perhaps rewards, are necessary.
It is interesting to note that, regardless of educa-
tion, physicians reported that they were extremely
confident in their knowledge of meperidine. This
finding was unrelated to age or education. The pre-
scription of meperidine has been scrutinized be-
cause of its unique pharmacology and toxicity [43,
45,49]. Thus, our findings are particularly impor-
tant because there are recommendations that mep-
eridine should be avoided or its use limited in light
of the potential for untoward side effects because its
metabolite (normeperidine) may cause seizures at
doses greater than 800 mg/day [50–53]. Both pri-
mary and specialty physicians reported a greater
knowledge of meperidine, Schedule III and IV opi-
oids (nontriplicate), and Schedule II opioid analge-
sics (triplicate). One limitation of this study is that
we did not have specific questions that addressed
their actual knowledge of meperidine or the other
modalities. No efforts were made to test physician
knowledge on the appropriate use of oral and intra-
venous meperidine. On the basis of the popularity
of meperidine, the physicians may not have accu-
rate knowledge despite their apparent confidence.
This suggests that physicians may not be accurate
in their judgments about their own knowledge re-
garding pain management. Our findings also sug-
gest lack of education regarding complementary
modalities that may be useful for the management
of pain. Furthermore, our findings suggest discor-
dance between what physicians actually know and
what they think they know. This result emphasizes




Michigan physician satisfaction with pain care 











Acute Primary 212 4.2 0.6 0.014
Specialty 116 4.4 0.8
Cancer Primary 150 3.8 0.9 0.016
Specialty 80 3.5 1
Terminally ill Primary 150 3.9 0.9 0.001
Specialty 73 3.4 1.1
Chronic Primary 213 3.3 1 NS
Specialty 113 3.2 1
 











Figure 5 Michigan physician satisfaction with pain care






may be a better way to determine their educational
needs.
Overall, the study group were satisfied with the
pain care they provided whether or not they had
experience treating the type of pain problem pre-
sented. Despite their high level of satisfaction with
their care of patients with acute pain, cancer pain,
or pain in terminal illness, this satisfaction is likely
misplaced because all types of pain continue to be
severely undertreated [28,54,55]. Furthermore, this
study did not evaluate the patient’s satisfaction with
their physician’s attention to or care of their pain
complaints. Our findings do suggest that there was
discordance between the physician’s overall goal of
pain management and their satisfaction with the
pain management they provide for chronic pain pa-
tients. The majority of physicians reported a goal of
absolute and complete to adequate pain relief for
acute pain, cancer pain, and pain associated with
terminal illness. However, the physician’s reported
a lower goal (i.e., adequate and complete to moder-
ate pain relief) for chronic pain. Although we were
surprised to find differences in the treatment goals
for the different types of pain, this finding may be
due to experience in caring for patients with diffi-
cult chronic pain problems. It is entirely conceiv-
able that lower expectations may be realistically
based on the physician’s practice. Nonetheless, phy-
sicians in the study group were universally less sat-
isfied with their management of chronic pain. We
can only speculate that their lower goals for manag-
ing chronic pain may reflect difficulty in treating
these complex patients, which may often require
specialty care. Clearly, further study is required to
determine whether this is due to less knowledge
about how to achieve higher pain relief goals in this
patient population.
Our respondents reported seeing patients with
chronic pain more frequently than patients with other
types of pain. They expressed less comfort and sat-
isfaction with their management of chronic pain.
These results, taken together, confirm that, although
assessment and treatment for chronic pain does oc-
cur, physicians have both lower expectations for
treatment outcomes and are less satisfied with the
care they are providing for chronic pain. The study
data may support the conclusion that physicians
recognize the added complications, challenges, and
inconsistencies of chronic pain compared with acute
pain, cancer pain, and the pain of terminal illness.
The reason for lower expectations and goals for
chronic pain relief deserve further study.
The identification of legislative barriers to the
treatment of pain may ultimately lead to better care
of patients with pain. Although the physicians did
not report undue regulatory prescribing of strong
opioids, it appears that perceptions of regulatory
scrutiny in the state of Michigan may have an effect
on the prescribing habits of physicians. The physi-
cians believed that prescribing strong opioids for
pain management would attract a medical review.
However, they also reported that the experience of
their colleagues with regulatory agencies had not
affected their prescription of strong opioids for
pain. Although we did not specifically evaluate pre-
scribing habits, in general the physicians did not
tend to endorse the utilization of chronic opioids
for the management of chronic pain. Weinstein
et al. also revealed that physicians were prejudiced
about the use of opioid analgesics for pain and
lacked knowledge about pain and its treatment [8].
This finding is consistent with the New York State
experience in which the introduction of special pre-
scription forms for Schedule II opioid analgesics
led to a reduction in the prescription of these drugs
[37]. These findings parallel and may contribute
further to the reluctance of physicians to prescribe
opioid analgesics for long periods to manage chronic
pain in conjunction with potential regulatory scru-




Michigan physician opinions on issues related to regulatory scrutiny
 
Opinions regarding regulatory issues
Agreement scores*
N Mean S.D.
Experience of my colleagues with regulatory agencies has affected my 
prescribing of strong opioids for pain 364 2.5 1.3
There is undue regulatory scrutiny of physicians who prescribe strong opioids 364 2.9 1.1




 affected by 
frequently prescribing strong opioids for pain 368 2.7 1.0




 affected by 
frequently prescribing strong opioids for pain 368 2.6 0.8
If I frequently prescribe strong opioids for pain management, I may attract a 
















reducing diversion remains controversial [38]. It
was surprising to find that when physicians did use
opioid analgesics for chronic pain management,
there was modest utilization of opioid contracts
with these patients. It is unclear whether this sug-
gests that physicians may also need education about
regulatory matters or that they justifiably feel that
they are not appropriate or beneficial.
Development of physician-specific educational
strategies for the management of different types of
pain may be necessary. For example, efforts have
been made to implement treatment guidelines, al-
gorithms, or disease state management practices.
Moreover, these efforts may especially be needed to
address physician attitudes, goals, and perceptions
regarding patients with chronic pain. Further study
could evaluate standardizing treatment of pain us-
ing a disease management approach.
To minimize the potential urge to intentionally
report untrue behaviors or attitudes (self-report
bias), the questionnaires were completed confiden-
tially. Despite broad coverage, we did not test for
representation bias resulting from regional differ-
ences in the practice of pain management or differ-
ences resulting from the type of physician practice.
However, other studies can be criticized for select-
ing physicians based on their membership in pro-
fessional organizations or their medical specialty
[28,30,46,56]. Because pain is ubiquitous and the
goal was to evaluate the status of pain management
by physicians practicing in the state of Michigan, a
comprehensive sampling frame using the Michigan
Board of Medical Licensure directory was chosen.
It was noteworthy that physician specialties that are
well represented in the American Pain Society and
the American Academy of Pain Medicine (e.g., an-
esthesiology, neurology and PM and R) were un-
derrepresented in this survey.
Providing reminders by mail (as done in this
study) as well as by telephone has been shown to
improve response rate [39]. In general, lower re-
sponse rates have been associated with physicians
and anonymous surveys [57]. Studies with greater
than 60% response rate are achievable in physician
populations [57]. However, the strategy used to cal-
culate the response rate in these studies is not al-
ways clear from the methods; neither is it clear
whether the investigators used monetary incen-
tives. It is known that monetary incentives may im-
prove response rates but may also introduce a selec-
tion bias [57]. Thus, we made a conscious decision
to defer utilization of tokens. Our survey was fairly
detailed and touched on a sensitive subject matter,
both of which may have reduced the response rate.
Nonetheless, we believe that our response rate was
acceptable for a population of physicians asked to
complete a four-page survey.
To evaluate nonrespondent bias, an abbreviated
questionnaire was used to determine reasons for
nonresponse. By using a large physician sample and
comparing their demographics to federal statistics,
we believe that a representative sample was ob-
tained [41]. Furthermore, analysis of the nonresponse
questionnaire suggests that there was no substan-
tive difference between those who responded and
those who did not. An article by Asch et al. clearly
articulates issues of response rate and bias: “Although
there are more opportunities for non-response bias
when response rates are low than high, there is no
necessary relationship between response rates and
bias. Surveys with very low response rates may pro-
vide a representative sample of the population of
interest, and surveys with high response rates may
not”[57]. Considering the aforementioned, we be-
lieve that our response rate is consistent with other
mail survey studies that have recruited physicians
[58]. If a bias is present, we believe that it did not
affect our conclusions in a meaningful manner.
Finally, this work emphasizes the considerable
variability in the physician practice of pain manage-
ment. Physician variability and perceptions of regu-
latory scrutiny may contribute to the undertreat-
ment of all types of pain. This is especially true as
regards chronic pain management. In addition, phy-
sician perceptions may lead to the unintentional
undertreatment of pain. This may be especially prob-
lematic for patients with chronic pain. Physician vari-
ability in their goals, knowledge, and attitudes based
on the type of pain may very well be a barrier to the
management of chronic pain. Furthermore, this
finding is supported by Weinstein and colleagues,
who reported that physicians often had negative views
about patients with chronic pain [8]. Although this
study was conducted in Michigan, these results may
reflect the status of pain management in other states.
Our results support increasing educational ef-
forts for physicians as well as the evaluation of cur-
rent health care and legislative policy regarding
pain management. Future studies will use the data
from this study to direct population-based research
focused on a larger physician sample to evaluate
physician prescribing habits. More study is also es-
sential to evaluate patients’ perceptions and satis-
faction with pain management in the context of
function and quality of life and to evaluate ways of
improving the quality of pain care in a cost-effec-
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